Efficacy of cinnamon in reducing anthropometric measurements in individuals with type 2 diabetes: a clinical trial.
- 2025-07-11
- Revista brasileira de enfermagem 78(3)
- José Cláudio Garcia Lira Neto
- Márcio Flávio Moura de Araújo
- Jardeliny Corrêa da Penha
- Maria Augusta Rocha Bezerra
- Bruna Karen Cavalcante Fernandes
- Thatiana Araújo Maranhão
- José Wicto Pereira Borges
- Marta Maria Coêlho Damasceno
- PubMed: 40667904
- DOI: 10.1590/0034-7167-2024-0380
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Sample size
- n = 140
- Population
- 140 participants, divided into an experimental group (n = 71) and a control group (n = 69) with type 2 diabetes
- Methods
- randomized, triple-blind, placebo-controlled clinical trial; experimental group consumed 3 g/day of encapsulated cinnamon
- Blinding
- Triple-blind
- Duration
- 90 days
- Funding
- Unclear
- Large Human Trial
Objectives
to evaluate the effectiveness of cinnamon (Cinnamomum verum) in reducing anthropometric measurements in individuals with type 2 diabetes.Methods
a randomized, triple-blind, placebo-controlled clinical trial was conducted with 140 participants, divided into an experimental group (n = 71) and a control group (n = 69). The experimental group consumed 3 g/day of encapsulated cinnamon for 90 days. Anthropometric variables were measured at baseline and at the end of the study, with intra-group comparisons performed using a paired t-test.Results
the majority of participants were women (69.2%) with a mean age of 61 years. Reductions were observed in weight (-0.8 kg, p =0.11), body mass index (-0.36 kg/m2, p =0.16), body adiposity index (-1.02%, p =0.38), waist circumference (-3.97 cm, p =0.67), neck circumference (-0.45 cm, p = 0.68), and hip circumference (-1.83 cm, p =0.49), none of which were statistically significant (p > 0.05).Conclusions
cinnamon supplementation resulted in reductions in anthropometric measurements compared to placebo, but these differences were not statistically significant.Research Insights
Reductions were observed in ... body adiposity index (-1.02%, p =0.38)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 3 g/day
Reductions were observed in ... body mass index (-0.36 kg/m2, p =0.16)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 3 g/day
Reductions were observed in weight (-0.8 kg, p =0.11)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 3 g/day
Reductions were observed in ... hip circumference (-1.83 cm, p =0.49)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 3 g/day
Reductions were observed in ... neck circumference (-0.45 cm, p = 0.68)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 3 g/day
Reductions were observed in ... waist circumference (-3.97 cm, p =0.67)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 3 g/day